These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 32192594)

  • 1. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas.
    Nicholson WK; Wegienka G; Zhang S; Wallace K; Stewart E; Laughlin-Tommaso S; Thomas L; Jacoby VL; Marsh EE; Wise L; Borah BJ; Spies J; Venable S; Anchan RM; Larry Maxwell G; Diamond M; Lytle B; Myers ER
    Obstet Gynecol; 2019 Aug; 134(2):261-269. PubMed ID: 31306318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
    Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
    Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
    Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
    Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
    Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
    N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
    Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
    J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
    Coyne KS; Margolis MK; Murphy J; Spies J
    Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
    Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
    J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.
    Borah BJ; Yao X; Laughlin-Tommaso SK; Heien HC; Stewart EA
    Obstet Gynecol; 2017 Nov; 130(5):1047-1056. PubMed ID: 29016510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
    Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
    J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
    Thao V; Moriarty JP; Stewart EA; Borah BJ
    J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study.
    Chen J; Li Y; Wang Z; McCulloch P; Hu L; Chen W; Liu G; Li J; Lang J;
    BJOG; 2018 Feb; 125(3):354-364. PubMed ID: 28421665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
    Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
    Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes and Beliefs about Hysterectomy in Patients with Uterine Fibroids.
    Duyar S; Tsai S; Milad MP; Chaudhari A
    J Minim Invasive Gynecol; 2023 Oct; 30(10):797-804. PubMed ID: 37245673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.
    Iversen H; Dueholm M
    J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
    Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
    BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.